You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天康生物(002100.SZ):豬流行性腹瀉滅活疫苗(XJ-DB2株)獲批為新獸藥
格隆匯 04-12 16:09

格隆匯4月12日丨天康生物(002100.SZ)宣佈,根據《獸藥管理條例》和《獸藥註冊辦法》等有關規定,經中華人民共和國農業農村部審查,准予公司及其子公司申報的“豬流行性腹瀉滅活疫苗(XJ-DB2株)”為新獸藥,核發《新獸藥註冊證書》。

豬流行性腹瀉滅活疫苗(XJ-DB2株)是由公司自主研發、自主生產,用於預防豬流行性腹瀉的產品。制苗用毒株為田間流行毒株;採用懸浮技術培養,經純化、滅活後,按一定比例與佐劑混合乳化製成。

與市場上同類產品相比,該疫苗有以下優勢:毒株屬於G2a亞型,彌補了市場無G2a亞型毒株疫苗的空缺;病毒含量高,半成品含量為107.5~108.5TCID50/ml;佐劑優秀,可有效刺激機體產生較高的黏膜抗體,解決了常規滅活疫苗不能產生黏膜抗體或產生黏膜抗體低的缺陷。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account